Published in Mol Cell Biol on December 01, 1995
Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol Cell Biol (2001) 5.61
STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med (1999) 2.36
Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. EMBO J (2000) 2.11
A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation. Genes Dev (1998) 1.99
p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation. Proc Natl Acad Sci U S A (1998) 1.73
Raf-1 physically interacts with Rb and regulates its function: a link between mitogenic signaling and cell cycle regulation. Mol Cell Biol (1998) 1.63
c-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesis. EMBO J (2002) 1.41
The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter. Mol Cell Biol (1997) 1.33
p53 mediates apoptotic crisis in primary Abelson virus-transformed pre-B cells. Mol Cell Biol (1999) 1.03
Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells. Mol Cell Biol (1997) 1.03
BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase CbetaII-dependent pathway. Mol Cell Biol (2000) 1.03
Oncogene-induced sensitization to chemotherapy-induced death requires induction as well as deregulation of E2F1. Cancer Res (2010) 0.94
Kinase-independent mechanisms of resistance of leukemia stem cells to tyrosine kinase inhibitors. Stem Cells Transl Med (2014) 0.82
Changes in p19Arf localization accompany apoptotic crisis during pre-B-cell transformation by Abelson murine leukemia virus. J Virol (2008) 0.80
p53 deficiency increases transformation by v-Abl and rescues the ability of a C-terminally truncated v-Abl mutant to induce pre-B lymphoma in vivo. Mol Cell Biol (2000) 0.79
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell (1993) 33.20
Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell (1993) 15.70
E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science (1992) 10.28
The E2F transcription factor is a cellular target for the RB protein. Cell (1991) 9.62
Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques (1990) 6.90
Organization and reorganization of immunoglobulin genes in A-MULV-transformed cells: rearrangement of heavy but not light chain genes. Cell (1981) 6.31
Functional macrophage cell lines transformed by Abelson leukemia virus. Cell (1978) 5.76
The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev (1992) 5.73
myc function and regulation. Annu Rev Biochem (1992) 5.33
Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J (1992) 4.21
The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. Genes Dev (1992) 4.20
Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev (1993) 4.14
Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell (1994) 4.01
The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol (1993) 3.75
E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. Proc Natl Acad Sci U S A (1989) 3.67
DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem Sci (1994) 3.32
Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo. EMBO J (1992) 3.15
A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J (1990) 3.07
E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci U S A (1995) 2.99
Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter. Genes Dev (1989) 2.82
A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell (1993) 2.80
Dominant negative MYC blocks transformation by ABL oncogenes. Cell (1992) 2.64
Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell (1985) 2.59
Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev (1994) 2.54
MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination. Proc Natl Acad Sci U S A (1992) 2.40
Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism. Cell (1985) 2.36
Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol Cell Biol (1993) 2.34
Differential modulation of cyclin gene expression by MYC. Proc Natl Acad Sci U S A (1993) 2.31
Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. Proc Natl Acad Sci U S A (1993) 2.17
The role of c-myc in cell growth. Curr Opin Genet Dev (1993) 2.17
The viral and cellular forms of the Abelson (abl) oncogene. Adv Virus Res (1988) 2.10
Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter. Proc Natl Acad Sci U S A (1990) 2.06
Yin-yang 1 activates the c-myc promoter. Mol Cell Biol (1993) 2.06
Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line. Mol Cell Biol (1986) 1.96
Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associated E2F-1. J Virol (1993) 1.78
Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr Opin Genet Dev (1993) 1.73
Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter. Proc Natl Acad Sci U S A (1988) 1.64
Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl. Mol Cell Biol (1989) 1.64
DP and E2F proteins: components of a heterodimeric transcription factor implicated in cell cycle control. Curr Opin Cell Biol (1994) 1.55
Differential complementation of Bcr-Abl point mutants with c-Myc. Science (1994) 1.52
Abelson leukemia virus induces lymphoid and erythroid colonies in infected fetal cell cultures. Cell (1981) 1.50
Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes Dev (1995) 1.50
Rapid thymomas induced by Abelson murine leukemia virus. Proc Natl Acad Sci U S A (1982) 1.49
mTFE3, an X-linked transcriptional activator containing basic helix-loop-helix and zipper domains, utilizes the zipper to stabilize both DNA binding and multimerization. Mol Cell Biol (1992) 1.49
Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein. Cell (1994) 1.44
Molecular requirements for transcriptional initiation of the murine c-myc gene. Oncogene (1989) 1.43
Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Oncogene (1994) 1.40
E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions. Oncogene (1994) 1.33
The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes. Genes Dev (1994) 1.24
G1/S-regulated E2F-containing protein complexes bind to the mouse thymidine kinase gene promoter. J Biol Chem (1994) 1.23
Three distinct elements within the murine c-myc promoter are required for transcription. Oncogene (1992) 1.21
Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context. EMBO J (1992) 1.18
Retracted Identification of a novel bone marrow-derived B-cell progenitor population that coexpresses B220 and Thy-1 and is highly enriched for Abelson leukemia virus targets. Mol Cell Biol (1989) 1.15
NF-kappa B-like factors mediate interleukin 1 induction of c-myc gene transcription in fibroblasts. J Exp Med (1992) 1.10
Nonmyristoylated Abl proteins transform a factor-dependent hematopoietic cell line. Mol Cell Biol (1992) 1.08
E2F transcription factor is a target for the RB protein and the cyclin A protein. Cold Spring Harb Symp Quant Biol (1991) 1.03
Protein phosphorylation required for the formation of E2F complexes regulates N-myc transcription during differentiation of human embryonal carcinoma cells. Oncogene (1993) 1.02
Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity. J Virol (1990) 0.98
Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1. Proc Natl Acad Sci U S A (1992) 0.97
Limited expression of C/EBP family proteins during B lymphocyte development. Negative regulator Ig/EBP predominates early and activator NF-IL-6 is induced later. J Immunol (1994) 0.96
Binding of NF-KB-like factors to regulatory sequences of the c-myc gene. Curr Top Microbiol Immunol (1990) 0.90
A novel NF-kappa B element within exon 1 of the murine c-myc gene. Oncogene (1992) 0.90
Formation of factor-independent hematopoietic multilineage colonies after Abelson virus infection. Blood (1988) 0.85
Structures and activities of activated abl oncogenes. Curr Top Microbiol Immunol (1989) 0.83
An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH. Cell (1980) 10.35
Two mRNAs can be produced from a single immunoglobulin mu gene by alternative RNA processing pathways. Cell (1980) 9.86
Two mRNAs with different 3' ends encode membrane-bound and secreted forms of immunoglobulin mu chain. Cell (1980) 6.32
Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas. Nature (1983) 5.97
A single VH gene segment encodes the immune response to phosphorylcholine: somatic mutation is correlated with the class of the antibody. Cell (1981) 5.87
myc function and regulation. Annu Rev Biochem (1992) 5.33
The synthesis and processing of the messenger RNAs specifying heavy and light chain immunoglobulins in MPC-11 cells. Cell (1978) 4.92
Nucleotide sequence of cloned cDNA of human c-myc oncogene. Nature (1983) 4.83
5' flanking region of immunoglobulin heavy chain constant region genes displays length heterogeneity in germlines of inbred mouse strains. Cell (1980) 4.62
Immunoglobulin heavy-chain enhancer requires one or more tissue-specific factors. Science (1985) 4.28
An immunoglobulin heavy-chain gene is formed by at least two recombinational events. Nature (1980) 3.99
Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia. Proc Natl Acad Sci U S A (1983) 3.90
Intragenic pausing and anti-sense transcription within the murine c-myc locus. EMBO J (1986) 3.69
Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain. Science (1979) 3.21
Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science (1997) 2.93
TREK-1 is a heat-activated background K(+) channel. EMBO J (2000) 2.82
Transcriptional enhancer elements in the mouse immunoglobulin heavy chain locus. Science (1983) 2.75
Posttranscriptional mechanisms are responsible for accumulation of truncated c-myc RNAs in murine plasma cell tumors. Cell (1985) 2.73
Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo. J Immunol (2000) 2.67
Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel. J Biol Chem (1999) 2.55
Mouse Cmu heavy chain immunoglobulin gene segment contains three intervening sequences separating domains. Nature (1980) 2.52
Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicol Teratol (2011) 2.41
MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination. Proc Natl Acad Sci U S A (1992) 2.40
Mouse c-myc oncogene is located on chromosome 15 and translocated to chromosome 12 in plasmacytomas. Science (1982) 2.40
Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science (1993) 2.40
An analysis of genes regulated by the multi-functional transcriptional regulator Yin Yang-1. Nucleic Acids Res (1994) 2.32
Nucleotide sequence comparison of normal and translocated murine c-myc genes. Nature (1984) 2.31
Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP. Genes Dev (1990) 2.31
Non-immunoglobulin-associated DNA rearrangements in mouse plasmacytomas. Proc Natl Acad Sci U S A (1982) 2.30
On immunoglobulin heavy chain gene switching: two gamma 2b genes are rearranged via switch sequences in MPC-11 cells but only one is expressed. Nucleic Acids Res (1982) 2.29
Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol Cell Biol (2000) 2.24
Lysophospholipids open the two-pore domain mechano-gated K(+) channels TREK-1 and TRAAK. J Biol Chem (2000) 2.16
An immunoglobulin promoter region is unaltered by DNA rearrangement and somatic mutation during B-cell development. Nucleic Acids Res (1982) 2.15
Yin-yang 1 activates the c-myc promoter. Mol Cell Biol (1993) 2.06
Common factor 1 is a transcriptional activator which binds in the c-myc promoter, the skeletal alpha-actin promoter, and the immunoglobulin heavy-chain enhancer. Mol Cell Biol (1991) 1.93
A negative transcriptional control element located upstream of the murine c-myc gene. EMBO J (1986) 1.92
A transcriptional enhancer 3' of C beta 2 in the T cell receptor beta locus. Science (1988) 1.91
The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1. EMBO J (2001) 1.91
The neuroprotective agent riluzole activates the two P domain K(+) channels TREK-1 and TRAAK. Mol Pharmacol (2000) 1.87
Multiplicity of germline genes specifying a group of related mouse kappa chains with implications for the generation of immunoglobulin diversity. Nature (1979) 1.85
Molecular cloning of translocations involving chromosome 15 and the immunoglobulin C alpha gene from chromosome 12 in two murine plasmacytomas. Proc Natl Acad Sci U S A (1982) 1.84
Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer Inst (2001) 1.84
Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition. J Biol Chem (2001) 1.80
Multiple DNA sequence elements are necessary for the function of an immunoglobulin heavy chain promoter. Proc Natl Acad Sci U S A (1987) 1.80
The first exon of the c-myc proto-oncogene contains a novel positive control element. EMBO J (1986) 1.80
Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases. Mol Cell Biol (1998) 1.79
Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene (1999) 1.78
BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nat Immunol (2000) 1.76
MAZ-dependent termination between closely spaced human complement genes. EMBO J (1994) 1.76
Mouse rDNA nontranscribed spacer sequences are found flanking immunoglobulin CH genes and elsewhere throughout the genome. Cell (1980) 1.74
Chromosome translocations clustered 5' of the murine c-myc gene qualitatively affect promoter usage: implications for the site of normal c-myc regulation. EMBO J (1985) 1.72
A model for the molecular requirements of immunoglobulin heavy chain class switching. Nature (1982) 1.69
Structure of the constant and 3' untranslated regions of the murine gamma 2b heavy chain messenger RNA. Science (1979) 1.68
Transcriptional repressor ZF5 identifies a new conserved domain in zinc finger proteins. Nucleic Acids Res (1993) 1.65
C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J Virol (1995) 1.64
A dominant negative form of transcription activator mTFE3 created by differential splicing. Science (1991) 1.63
The immunoglobulin class switch: beyond "accessibility". Immunity (1997) 1.55
Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals. Mol Cell Biol (1999) 1.55
Immunoglobulin heavy-chain constant-region genes. Cell (1982) 1.53
Transcriptional regulation during B cell development. Annu Rev Immunol (1998) 1.52
DNA sequence associated with chromosome translocations in mouse plasmacytomas. Proc Natl Acad Sci U S A (1982) 1.51
Products of a reciprocal chromosome translocation involving the c-myc gene in a murine plasmacytoma. Proc Natl Acad Sci U S A (1984) 1.50
Molecular determinants of NF-kappaB-inducing kinase action. Mol Cell Biol (1998) 1.49
mTFE3, an X-linked transcriptional activator containing basic helix-loop-helix and zipper domains, utilizes the zipper to stabilize both DNA binding and multimerization. Mol Cell Biol (1992) 1.49
Nuclear transcripts of mouse heavy chain immunoglobulin genes contain only the expressed class of C-region sequences. Science (1979) 1.48
Complete nucleotide sequence and properties of the major species of glycine transfer RNA from wheat germ. Biochemistry (1977) 1.44
Regulation of expression of the c-myc proto-oncogene. Bioessays (1987) 1.43
Molecular requirements for transcriptional initiation of the murine c-myc gene. Oncogene (1989) 1.43
Nucleotide sequence and properties of the murine gamma 3 immunoglobulin heavy chain gene switch region: implications for successive C gamma gene switching. Nucleic Acids Res (1982) 1.42
Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells. Mol Cell Biol (1986) 1.42
A transcriptional repressor of c-myc. Nature (1989) 1.41
A cis-acting element in the promoter region of the murine c-myc gene is necessary for transcriptional block. Mol Cell Biol (1989) 1.40
An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH. 1980. J Immunol (2004) 1.40
BLIMP-1: trigger for differentiation of myeloid lineage. Nat Immunol (2000) 1.39
In vivo functional analysis of in vitro protein binding sites in the immunoglobulin heavy chain enhancer. Nucleic Acids Res (1988) 1.39
The endogenous immunoglobulin heavy chain enhancer can activate tandem VH promoters separated by a large distance. Cell (1985) 1.39
Evidence that immunoglobulin VH-DJ recombination does not require germ line transcription of the recombining variable gene segment. Mol Cell Biol (1998) 1.38
Differential stability of c-myc mRNAS in a cell-free system. Mol Cell Biol (1988) 1.37
Isolation, purification, and properties of mouse heavy-chain immunoglobulin mRNAs. Biochemistry (1978) 1.35
SV40 enhancer-binding factors are required at the establishment but not the maintenance step of enhancer-dependent transcriptional activation. Cell (1986) 1.32
Contributions of transcriptional and post-transcriptional mechanisms to the regulation of c-myc expression in mouse erythroleukemia cells. Genes Dev (1987) 1.31
CHUK, a new member of the helix-loop-helix and leucine zipper families of interacting proteins, contains a serine-threonine kinase catalytic domain. Cell Mol Biol Res (1995) 1.30
Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases. EMBO J (1999) 1.30
Ig/EBP (C/EBP gamma) is a transdominant negative inhibitor of C/EBP family transcriptional activators. Nucleic Acids Res (1995) 1.30
Chromatin structure of the murine c-myc locus: implications for the regulation of normal and chromosomally translocated genes. EMBO J (1985) 1.30
Chromosomal locations of mouse immunoglobulin genes. Proc Natl Acad Sci U S A (1978) 1.29
On the existence of polyadenylated histone mRNA in Xenopus laevis oocytes. Cell (1976) 1.24
Proteins binding to site C2 (muE3) in the immunoglobulin heavy-chain enhancer exist in multiple oligomeric forms. Mol Cell Biol (1989) 1.21
Repression of c-myc is necessary but not sufficient for terminal differentiation of B lymphocytes in vitro. Mol Cell Biol (2000) 1.21
Translation of a specific mRNA from Escherichia coli in a eukaryotic cell-free system. Biochem Biophys Res Commun (1976) 1.21
DNA rearrangements in MPC-11 immunoglobulin heavy chain class-switch variants. Proc Natl Acad Sci U S A (1982) 1.21
The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus (2010) 1.21
Nanoelectromechanics of methylated DNA in a synthetic nanopore. Biophys J (2009) 1.20
Abnormal recombination of Igh D and J gene segments in transformed pre-B cells of scid mice. J Immunol (1988) 1.20
Alternative modes of c-myc regulation in growth factor-stimulated and differentiating cells. Oncogene (1987) 1.19